Imunon Inc reports results for the quarter ended June 30 - Earnings Summary
Imunon Inc reports results for the quarter ended June 30 - Earnings Summary
Imunon Inc IMNN.OQ reported a quarterly adjusted loss of 54 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.87. The mean expectation of five analysts for the quarter was for a loss of 93 cents per share. Wall Street expected results to range from $-1.34 to -46 cents per share.
Reported revenue was zero; analysts expected zero.
Imunon Inc's reported EPS for the quarter was a loss of 54 cents.
The company reported a quarterly loss of $2.81 million.
Imunon Inc shares had fallen by 8.4% this quarter and lost 57.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 6.4% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Imunon Inc is $13.00, about 87.5% above its last closing price of $1.63
This summary was machine generated from LSEG data August 11 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.93 | -0.54 | Beat |
Mar. 31 2026 | -1.11 | -0.84 | Beat |
Dec. 31 2025 | -1.17 | -1.99 | Missed |
Sep. 30 2025 | -1.81 | -1.16 | Beat |